As of 3:59pm ET
| -1.01 / -32.58%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 7.76, with a high estimate of 7.76 and a low estimate of 7.76. The median estimate represents a +271.17% increase from the last price of 2.09.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.